olfactory receptor family 10 subfamily D member 1 pseudogeneGenealiases: HTPCRX03 · OR10D2P · OST074
Q-omics provides the consensus-scored OR10D1P profile across patient tissues and cancer cell-line models. OR10D1P expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, OR10D1P is differentially expressed in 8, with the highest sampling consensus in LUSC. Additionally, OR10D1P RNA expression shows 6,755 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight BLCA, LUSC, and KIRP as cancer lineages where OR10D1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR10D1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR10D1P survival associations across molecular data types. OR10D1P RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR10D1P RNA expression–survival associations across cancer types. High OR10D1P expression shows unfavorable associations in STAD, LUSC, LIHC and LUAD, but favorable associations in BLCA and PAAD. The BLCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify BLCA as the clearest survival context for OR10D1P RNA expression.
This table summarizes OR10D1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for OR10D1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR10D1P shows lower tumor expression in LUSC, BRCA, COAD, BLCA and KICH and higher tumor expression in CHOL. The LUSC box plot shows higher OR10D1P RNA expression in normal versus tumor tissue (log2 FC = −0.075, t-test p < 0.001).
This table shows molecular features associated with OR10D1P in patient tissues and cancer cell lines. In patient samples, OR10D1P shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
